MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

    R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate clinical and biomarker changes from spinal cord stimulation (SCS) in Parkinsons Disease (PD) under sham controlled randomized evaluation. Background: SCS has been proposed…
  • 2024 International Congress

    Functional connectivity enhances prediction of STN DBS motor outcomes

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To assess the predictive value of functional and volumetric MRI data in comparison to clinical data alone for STN DBS outcomes. Background: While STN…
  • 2024 International Congress

    Levodopa response is an inadequate and often biased correlate of STN-DBS outcomes

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To investigate the reliability of the relationship between levodopa response and subthalamic nucleus (STN) DBS outcomes in Parkinson disease (PD). Background: Levodopa response (LR)…
  • 2024 International Congress

    Effect of Target Selection on Mood, Pain, and Medications after DBS in PD

    J. Jiao, B. Brumbach, Y. Lin, A. Ko, D. Safarpour (Palo Alto, USA)

    Objective: To describe the association between medication adjustments with mood and pain following bilateral deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Depression, anxiety,…
  • 2024 International Congress

    PD GENEration: A cross-sectional evaluation of cognitive complaints in Parkinson’s disease (PD) patients according to GBA1 and DBS status

    J. Son, K. Ghosh Galvelis, A. Naito, J. Beck, R. Alcalay, G. Pal (New Brunswick, USA)

    Objective: To compare differences in cognitive complaints in Parkinson’s disease (PD) patients who are GBA1 mutation carriers and non-carriers either with or without DBS. Background:…
  • 2024 International Congress

    Real-world Programming and Sensing from Adaptive Deep Brain Stimulation for Parkinson’s Disease in Japan

    G. Oyama, K. Kimura, H. Kishima, N. Murase, Y. Tsuboi, T. Tsuboi, T. Takezaki, Y. Higuchi, T. Hashimoto, Y. Shimo, T. Brionne, I. Buffin, K. Hidaka, F. Coletti, R. Amit, N. Morelli, H. Mure, H. Oshima (Tokyo, Japan)

    Objective: To characterize programming configurations and local field potentials (LFP) control parameters in a multicenter, real-world cohort of patients receiving deep brain stimulation (DBS) for…
  • 2024 International Congress

    Parkinsonism after Internal Globus Pallidus Deep Brain Stimulation in Dystonia

    T. Lampreia, D. Martins, L. Guedes, M. Mendonça, M. Coelho (Loures, Portugal)

    Objective: To evaluate the frequency and predictors of parkinsonism after GPi-DBS in dystonia; to describe the clinical characteristics and stimulation changes performed to improve parkinsonism.…
  • 2024 International Congress

    Cholinergic brain vulnerabilities associate with diabetic comorbidity in Parkinson disease

    G. Carli, P. Kanel, T. Brown, S. Roytman, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: We aim to explore differences in brain cholinergic nerve terminal integrity between Parkinson's disease (PD) patients with and without comorbid diabetes, utilizing a highly…
  • 2024 International Congress

    A novel single-cell reporter identifies regulators of the endogenous PINK1-Parkin mitochondrial quality control pathway

    J. Thayer, X. Huang, J. Hawrot, D. Ramos, M. Ward, D. Narendra (BETHESDA, USA)

    Objective: We aimed to identify genome-wide regulators of the PINK1-Parkin pathway using a novel flow cytometry reporter, endogenously tagged MFN2, as a readout of the…
  • 2024 International Congress

    Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson’s Disease

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to explore the efficacy of opicapone (OPC) 50 mg versus an extra 100 mg levodopa (L-dopa) dose to treat early wearing-off…
  • « Previous Page
  • 1
  • …
  • 445
  • 446
  • 447
  • 448
  • 449
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley